-.ispatbyrLRstfme,tseNM(CMWS682)mdbythcHawud H~M~I a r t i t u t c I ble for coupling these meptos to tbe cell interior. We were p a r t i c u l a r l y i n t r i g u a d b y t h e i d e a t h a t l y m~p r otein tyrosine kinases might couple these nceptors to other biochemical pathways. Our theory was not daived &om detailed k n o w about the importance of tyrosine -tion.
Tcell antigen naptor. Thereafter, changes in the turnover of membnne pbpblipids (Fig. 1) and the accumulation of high macentrations of intmcellular calcium oocur transiently. All these almatbns precede c4mges in gene expmdon, especially the activation of a set of genes important for prol8kation. Included among these are genes enadkg the transcription he tors, genes encoding lymphokine mcptom, and the lymphokine genes themselves (1). T h events together permit lymphoqtes to proceed along a course that ultimately win kad to DNA replication and proliferation.
Two fbdamental problems exist in undmtanding ?his sequence &events. F u s t , we have no idea of the causal relationships among these various biochemical alterations. Is tyrosine phoaplrorylstion a cause of these subsequent events? Second, we have no idCB Itow the receptor mdecuks on the surfaces of lympboid & effect these biochemical changes. This article focurcs on that problem.
Amysd on tbe T lymphocyte surbce is a set of molecules that traasldn dgmb to the cell interior. Tlusc structurally related -.ispatbyrLRstfme,tseNM(CMWS682)mdbythcHawud H~M~I a r t i t u t c I ble for coupling these meptos to tbe cell interior. We were
p a r t i c u l a r l y i n t r i g u a d b y t h e i d e a t h a t l y m~p r o -
tein tyrosine kinases might couple these nceptors to other biochemical pathways. Our theory was not daived &om detailed k n o w about the importance of tyrosine -tion.
It simply seemed that in many respects the signal transduction cescade~tcdbylymphocyteeenwlrfaeereceptorsresembled t h e k i n d o f~t r a n s
d u c t i o n~o c c u r r i a g w i t h s t i m u -
lation of grrwth EPdor mcpton known to possess intrinsic
prorrintymdoe-activity(5).
Withtbis~inmind,~stpdiadavariayoflymphoid cell lines, searching for those with elevated tyroshe kinase activity. One of the cell lines-a mouse Moloney murine leukemia virus-transformed cell line called LSTRA-was particularly informative.
The LSTRA cell line was found to contain high levels of a specialized protein tyrosine kinase of 56 kD apparent molecular mass. We were able to use molecular biologic techniques to identify the gene that encodes this molecule (6) and learned that it is a typical nonreceptor protein tyrosine kinase of the type exemplitied by p60". 5 The src-family of protein tyrosine kinases all share a similar structure. These molecules ~I E myrktoylated at their amino termhi, which presumably assists their interaction with the inner leaflet of the plasma membrane. Across the entire stnrdure, t h e distinct regions can be identitied (Fii 2). F i a unique amjno terminal domain stnacture, about 70 amino acids in l e e a p p e a c~t o c 0 l l t r o l d i r t c t i n~0 1 1~t l l n c e p t o r s b Y~ Then a set of sn: homology motifs appean, including sequthat are involved in the binding of ph ' e itself, and, m y , there is a carboxymmina, -% t h e bmims end of the molecule responsible for phosphorylating substrates (7). Included in the kinase domain is a critical site of regulation: a tyrosine near the carboxy terminus that is ordinarily phosphorylated in vivo (8) . If the phosphate is stripped from this site, the kinase becomes much more active. Study of this activity can be u s e M in investigating the function of these molecules.
There are now eight wdkkuibed members of the src family. It is important to remember that these molecules are usually specialized for expression in hematopoietic cells. For precursors in the thymus and throughout the set of maturation stages defining T-cell development. The structure of p56Ick closely resembles that of a number of oncoproteins, suggesting that it may be involved in controlling replication. Indeed, it is possible to demonstrate directly that the lck gene is an oncogene that can confer on certain cells the ability to grow in the absence of appropriate growth factors and appropriate substrate contacts. For example, we have used transcrip tional regulatory sequences from the mouse metallothionein promoter to drive the expression of normal and mutated Ick cDNA. Mutations were introduced at the 3' end that change a regulatory tyrosine codon to a phenylalanine or to a termination codon.
Wild-type fibroblasts transfected with constructs that direct the expression of the ordinary Ick gene do not exhibit morphologic abnormalities. However, the mutated forms of the Ick gene efficiently and successfully transform these fibroblasts, yielding cells that become highly refractile, elaborate long spindly processes, and adhere poorly to substrates. These Ick fibroblasts grow in a contact-independent fashion, form tumors in nude mice, form colonies in soft agar, and, by all criteria, are transformed. Thus, a single-point mutation unmasks the transforming potential of the Ick gene (1 1).
Intriguingly, the Ick gene is positioned at a site (lp34) of frequent chromosomal abnormalities in human malignant disease, particularly non-Hodgkin lymphomas (12). Recently, two groups have demonstrated that the Ick gene is positioned at the breakpoints of certain chromosomal translocations observed in human T cell acute lymphoblastic leukemias (I 3). In these cases, the Ick gene was juxtaposed with the T-cell receptor 8 locus on chromosome 7. These observations provide reason to believe that the Ick gene can contribute to the pathogenesis of at least some forms of human malignant disease, particularly lymphoid malignancies.
None of this theorizing advances our understanding of what the Ick gene actually does; however, it suggests that p56" may behave as a signal transduction molecule involved in the control of replication or those early activation events in T lymphocytes that give rise to proliferation. Recent studies demonstrate that p56' * physically associates with the CD4/CD8 coreceptor molecules on the T-cell surface. These observations argue that p56lCk may be brought into the T-cell receptor complex at the time of antigen recognition and may be directly involved in transmitting signals from that antigen receptor complex.
Studies by our group and others have defined the mechanism of association of CD4 and CD8 with p56Ick and have shown that cysteine residues near the N terminus of ~5 6 '~ and the C terminus of these coreceptors are crucial for this interaction. Intermp tion of any of these four cysteine residues completely destroys the association (14).
Thus, the amino terminal domain of p56lCk is involved in permitting the molecule to associate with the T-cell antigen receptor complex by its interaction with the coreceptors, CD4 and CD8. This observation gives rise to a fairly simple hypothesis: Under ordinary circumstances, p56lCk is in some sort of equilibrium state interacting with this coreceptor. At the time of antigen recognition, p56lCk becomes involved in the complex and becomes activated, presumably by dephosphorylation of a carboxy terminal tyrosine residue. Indeed, several groups have demonstrated that the CD45 phosphotyrosine phosphatase can dephosphorylate tyrosine 505 and hence activate p56Ick in precisely the fashion previously explored using mutant Ick cDNA introduced into fibroblasts (1 5).
To test this model, we hoped to artificially augment or decrease the amount of p56lCk activity present in otherwise normal T lymphocytes, that is, in transgenic mice. Such experiments have numerous advantages over conventional transfection studies. First, the signaling molecules are expressed in a normal cellular context, obviating the use of cell lines that invariably exhibit abnormal signaling properties. Second, all potentially relevant lymphocyte subsets can be simultaneously examined. It is not clear that all lymphocyte subsets can be cultured in vitro with the same efficiency. The advantage of using this in vivo system is that all potentially relevant lymphocyte subsets can be simultaneously targeted. Finally, the significance of signaling pathways in lymphocyte development is readily addressed in transgenic mice, and there are no satisfactory in vitro models for lymphocyte development.
To perform these experiments, it was necessary to characterize transcriptional regulatory elements that would permit us to direct the expression of signaling molecules, specifically to lymphocyte subsets. The transcriptional regulatory element that we selected is derived from the Ick gene itself. The Ick gene has two transcrip tional regulatory regions separated by 35 000 bases of germline DNA. These two "promoters," the proximal or 3' promoter and the distal or 5' promoter, function in a developmentally regulated fashion (16, 17) . The proximal promoter is active principally in thymocytes and turns off at the time that thymocytes exit the thymus and populate the periphery. In contrast, the distal promoter is somewhat active in the thymus, but functions primarily in periphenl T ceils. Through careful examination of the regions adjacent to these transcription start sites, we identified sequence , elements capable of directing the tissue-specific and temporally correct expression of heterologous DNA elements in transgenic animals.
We have used these promoter elements to manipulate the expression of three potentially important signaling molecules: guanine nucleotide-binding proteins of the Gi type, p56lCk itself, and another closely related protein-tyrosine kina~e-p59/~. Each set of experiments has proved quite revealing.
To examine the function of p56Ick, a piece of the lck gene, including all of its coding region and the proximal Ick promoter, was juxtaposed with 3' untranslated region sequences derived from the hGH gene. These hGH sequences were included to "-provide a reasonable, reliable marker for ex#glion at the RNA -1 * level.
Using an hG in the thy* Theseatetheex in the t h w u s but turns 08 at the time tBoaltitplocytes migsste (La). The tumorsane usually detedable by 3 wk of life, and most 100-ofthe animals are dead by the time they are 2 mo old, which presents difliculties when one wishes to maintain lines of these mice. The tumors invariably consist of immature thymoblasts that do not have T e l l receptors on their surfaces, and in most 68-cases these thymoblasts are hekmgeneous with respect to expres;. sion of C W or CD8.
-C The pattern of tyrosine phosphorylation in these cells is r e 5, markable in its close resemblance to that observed in the LSTRA tumor cell line that we originally used to define the lck gene, . , I Simply looking at the pattern of phosphotyrosine socumulation c; c:' using a phospho~naimmunoblotting technique in LSTRA+., !I- (Fig. 4) ertia. - observed in the thymocytes of transgenic animals (Fig. 6 ) as compared with littermate controls (23). Virtually every transgenic th ocyte expresses p 5 P from the proximal Ick promoter, the p5 p is therefore much more abundant and much easier to detect. Of course, no increase in p5ah" expression occurs in the spleen because the proximal lck promoter turns off at the time that thymocytes populate the periphery. Lymph node T cells are similarly unaffected.
Thymocytes that overexpress p 5 P become, by all criteria, hyperstimulable. In response to antigen receptor stimulation, these thymocytes rapidly augment intracellular calcium levels, release large amounts of IG2, and proliferate up to 10 times better than normal. An example of the improved calcium response is shown in Figure 7 . Transgenic thymocytes respond to lectin mitogen or to anti-3 antibodies by rapidly accumulating high levels of intracellular free calcium. The response outstrips that of littermate controls with respect to both rapidity and extent. These observations provoked a much more interesting experiment. A lysine residue within the catalytic domain of p 5 P , by analogy with a similar lysine in the catalytic domain of the cAMPdependent protein kinase, is crucial for phosphate transfer (23). It was possible, by mutating this lysine residue, to create a catalytically inactive version of p 5 P . When the nonfunctional kinase was expressed in transgenic thymocytes, no improvement was observed. Hence, the kinase activity of p 5 P is required for its positive effects on T a l l stimulation. However, the "deadUfln experiment proved even more interesting because the presence of the inactive kinase actually com- three types of thymocytes with a calcium ionophore and phorbol ester, thereby bypassing the T a l l receptor, yields identical proliferative responses in each case. Hence, by augmenting the expression of these protein-tyrosine kinases, we have learned something important about the way in which signals are coupled to the T-cell antigen receptor. Antigen recognition by the T-cell receptor no doubt provokes activation of a variety of signal transduction elements. But one of these is certainly p 5 P , which must be present in active form to permit signaling by mature thymocytes.
Other data permit elaboration of a somewhat improved model for signal transduction from the T-cell antigen receptor complex (Fig. 8) . The data reveal that p56@ interacts with the CD4 and CD8 coreceptors, p 5 P interacts with the T-cell receptor itself uia i@ CD3 amponents, and both of these participgte in signnl t n w d d 0 8 events that mediate lymphocyte activation. These molecuks npresent potentially important &gets for pharmacok t & hamiention in neoplastic and autoimmune diseasff A&wwIlecigments. The author thanks Kathy Fopbush, who generated all the transgenic animals ased in these experiments, and the very gifted graduate students and postdoctoral fellows who have been involved in p e r f b d q these shrdies. 
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and then come back with the nonnel stimulating TCen nceptor, itdoesnotmpond.WhathashappenedtothelaKl Dr. Perlmum That is an i nt er&@ phenomenon. The Ickencoded protein, p56, undergoeJ a modi6cation af& activation of T lymphocyte that lresults in its conversion to forms genericaUy called p6061 that have reduced mobility when visualized using eledmphoretic procedures. This modification, associated with seine phosphorylation in the amino-tamid region, can be eiktively stimulated by phorbol esters. In the normal activ a t i o n~e~~, v i r t u a l l y a l l t h e p 5 6 i s~0 n~t o t h i s p 6 0 fbm, and transaiption of the Ick gene dedines transiently. We t h i n k~m e a n s t h a t t h e c e l l i s~s o m e x x t o f k d b a c k tfaad-n;
hmtional Ick prosein <tisappearJ, and whatever protein k there is rapidly converted to this p60 form.
We hrve been unabk to desd'be precisely what catalytic diffaeaQeJ exkt between the p60 and the p56 forms. The ability t o 8upjm-t this traasfibrmation fiom p56 to p60 is a unique pmpertyOfhemrrtopoieticc€?kIfmphcep56into~b~ %or cxampk, pihorbol stus win not stimulate that transition from p56 to p60. A specific pathway is probably involved in altering the activation sequence.
Dr. Schreiber: Have you looked at serine and thonine phosphorylation in terms of Toell receptor activation and its potential function? Dr. Perlmutter: There are a large number of serine/threonine kinases. Numerous investigators have looked at alterations in the activity of certain specific serine/threonine kinases, e c ulady casein kinase II, the S6 ribosomal kinases, and the map2 or erk kinases. The activity of these kinases does change during the activation sequence. We suspect that the increase in activity of many of these kinases is the result of this tyrosine phosphorylation-induced cascade. But neither we nor to my anyone else has evidence that tyrosine phosphoryiati for the interaction? In many cases, it has been possible to do that. This is a roundabout way of addressing your question.
In certain circumstances, it is apparent that the association of a kinase with a protein-p56, CD4, and CD8 are good examples-is important. We can perform mutations that disrupt that association, leave the kinase intact, and show that these have specific effects on a CDCmediated process. We have learned from elegant studies done by Singer and Kupfer, Janeway, and others that CD4 associates with the T-cell antigen receptor complex. Thus, there is reason to believe that in such a situation we bring kinases into a complex. Moreover, there is overwhelming evidence from the growth factor-receptor field that proteintyrosine kinases usually are activated by forming multimers. The best hypothesis with regard to kinase regulation is that in one fashion or another we bring more of these molecules together, presumably by bringing cell surface structures together, because, of course, the kinases do not penetrate the membrane. In general, the logic is 100% correct; the specifics are mysterious.
Dr. Hershfield: Regarding the expression of lck, is that in cells that are absolutely committed to the T-cell lineage? If you were to inhibit or in some way block that expression, are the cells in which lck would have been expressed capable of any other lineage differentiation at that point?
Dr. Perlmutter: I can tell you the results of experiments that address that point. The lck gene is expressed in lymphoid cells and NK (natural killer) cells. In our experience, the gene is expressed in B lymphocytes at levels about 20-fold lower than in T cells. The results vary from investigator to investigator. B-cell lines often express p56, but we do not know whether normal B cells really express p56 or whether there are always some contaminating T cells or NK cells. Eliminating lck function has a deleterious effect on T-cell formation. We have shown that effect using the dominant negative approach. Tak Mak has done the same by knocking out the gene.
In either case, the animals do not really have a thymus. They have thymic stroma, but there are only about a million cells in the thymus. The cells are all immature thymoblasts that cannot progress. The animals do have B lymphocytes. It appears from these experiments that Ick is required for thymocyte develop ment, but apparently not for B lymphocyte development, at least in this system. Dr. Gelfand: In the overexpressed p56 with a predominance of the double negatives, it is thought that some of these cells may express IL-2 receptors that, as you suggest, may be link signaling to p56. Do these cells respond to IG2? Dr. Perlmutter: That is a good question. We have done two relevant experiments. There is a block in development in animals that overexpress p56. We have dissected that block carefully and found it to be remarkably specific. It is a block in the joining of variable regions of the j3 chain to the functioning of DJ joint segments. We correct that block in development simply by putting in a functionally rearranged T-cell receptor j 3 chain that seems to be independent of IG2 receptor function. However, in animals that are expressing a dead version of lck, the cells that accumulate are all IL-2 receptor-positive. That is consistent with a model in which Ick is required for an early intrathymic signal, and we have blocked the ability to deliver that signal. But in animals that lack IG2, thymocyte development proceeds normally. If there is a signal, it is delivered by some other ligand.
Dr. Gelfand: My second question concerns the cause and effect of the kinase, particularly in the fyn overexpression. With the dead kinase, is it possible that you are driving a different cell to differentiate? Is it not so much cause and effect, but rather the ability of the cell to respond? Dr. Perlmutter: Yes, that is always possible. The cell would have to be common and one that we cannot distinguish using any available markers. We have disrupted the fyn gene in other experiments, so we have animals that do not express this protein.
With our method, we disrupt just the exon required for expression offyn in T cells. They have thefyn gene, but not the specific form. In those animals, the thyrnocytes do not signal. On stimulating them with anti-T-cell receptor, Con A (concanavalin A), or whatever, we get very little calcium flux, no proliferation, no IL-2 release, and so forth. Despite the fact that the thymocyte number and subset representation are normal, cells leave the thymus and populate the periphery in a normal fashion. The kinetics of this process appear normal. Although signaling is completely disrupted in the ways we usually measure it, that signal is not required for normal development or for normal antigen-specific selection. This intriguing observation suggests that we are probably not recruiting a separate population; we have only eliminated a nonessential function.
Dr. Gelfand: Is this contrary to the CDfmediated apoptosis hypothesis?
Dr. Perlmutter: Probably not. Other signals probably suffice for CD3-mediated deletion. I believe the apoptosis phenomenon is calcium dependent. In parallel experiments placing the muscarinic receptor into these animals and stimulating them with carbachol, the cells undergo apoptosis beautifully.
Dr. Gelfand: What do you mean by "hyperproliferation"-more cells capable of responding, more cycles? Theoretically, the process is an all or nothing phenomenon for a single cell.
Dr. Perlmutter: More cells are capable of responding. Ordinarily, there is a transition point as cells go from double positive to single positive where they upregulate p 5 9 . We have given 1 p5YYn to everyone so that the end result is a lot more proliferation; 1 many more cells effectively couple from the T-cell receptor. seems to have almost no consequences. We expected that we would change thymocyte selection dramatically in such populations and see a range of different T-cell receptor types coming out. Every attempt we have made to identify that change has failed. That probably tells us something, but it might be difficult to see a change in T-cell receptor repertoire. Presumably we have altered the threshold for selection. Cells that would ordinarily not be selected at all, and hence would disappear, now can be selected. Cells that ordinarily would be selected now would be negatively selected because they stimulate too well. Such a change might not alter the representation of T-cell receptor a and j3 chain use in any convincing way. If we cross those animals with T-cell receptor transgenics, as we have done, we might not be able to alter the repertoire, because the T-cell receptors used in such experiments are efficient at selection anyway. We cannot make the selection better. Dr. Levinson: It might not have an effect on the selection of specific V betas detectable with serologic reagents, but perhaps it could let cells sneak through that otherwise would not have I gotten through with regard to autoimmune activity. Have any of those animals survived long enough to take a look at that? Dr. Perlmutter: Yes, our animals seem to have a normal lifespan. They never develop autoimmune disease that we can detect. Moreover, there are no abnormalities in mixed lympho-
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